## TEAM: Atlassian Corporation - XLK: Technology

### Executive Summary

No thesis match: MRS_20 3.8% below STRENGTH zone (4.0-10.0%); PEG 1.65 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($153.73)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 13 ($0.53M) |
| Sells | 126 ($27.91M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 36.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 11.0% (+6.0%)
- Blackrock Inc.: 6.3% (-1.4%)
- BAILLIE GIFFORD & CO: 4.8% (-4.8%)
- JPMORGAN CHASE & CO: 2.9% (+22.6%)
- State Street Corpora: 2.3% (+1.9%)

### Key Risks

1. Heavy insider selling: $28M sold (126 transactions in 90 days).
2. Long-term trend broken: trading 11.4% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.65 elevated, pricing in significant growth expectations. Insider selling cluster ($27.9M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $43.3B |
| Beta | 0.90 |
| 52W Range | $139.70 - $326.00 |
| Short Interest | 2.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.65 |
| Forward P/E | 29.2 |
| Current P/E | 33.7 |
| YoY Growth | 15.6% |
| EPS Direction | RISING |

### Technicals

MRS_20 stable at 3.8% (minimal 5-day change). Below STRENGTH zone by 0.2pp (needs >4.0% for momentum thesis). MRS_5 (-0.1%) diverging from MRS_20 - short-term weakness emerging. AM_20 at 4.4% shows strong absolute momentum above own 20MA. Outperforming sector by 3.6pp, stock-specific strength. Below SMA200 (0.89x), long-term trend not supportive. MACD histogram positive (0.76), confirming momentum. RSI neutral at 60. OFD pattern: +SUL (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 3.76% (CS: 78) | Neutral |
| RSI_14 | 59.7 | Neutral |
| MACD Histogram | 0.76 | Bullish |
| vs SMA20 | 1.044x | Above |
| vs SMA50 | 1.044x | Above |
| vs SMA200 | 0.886x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $164.45
- **Stop Loss:** $153.73 (6.5% risk)
- **Target:** $175.17 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 111
- **Position Value:** $18,253.95
- **Portfolio %:** 18.25%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-01-29 (Est: $1.14)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.84 | $1.04 | +24.1% |
| 2025Q2 | $0.85 | $0.98 | +14.6% |
| 2025Q1 | $0.93 | $0.97 | +4.8% |
| 2024Q4 | $0.76 | $0.96 | +27.1% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*